メインコンテンツにスキップ
検索

Latest version enhances efficiency, compliance, and user experience for PK scientists

ペンシルベニア州ラドナー: 2025年12月16日 — バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced the release of Integral 25.10.1, a focused update designed to deliver greater efficiency, enhanced connectivity, and an improved user experience for pharmacokinetic (PK) scientists and Phoenix® users.

Integral software streamlines regulated and exploratory PK workflows within a single, secure environment. Built with strong 21 CFR Part 11 compliance and robust auditing functionality, Integral enables organizations to support both GxP and non-GxP PK studies in one centralized repository, ensuring data integrity, traceability, and full regulatory readiness.

“The latest version of Integral builds on Certara’s vision of enabling scientists to work faster, smarter, and with full confidence in their data,” said Martin Snyder, President, Certara Data Science Software. “This release enhances automation, strengthens compliance, and deepens connectivity across the Phoenix ecosystem, helping our customers streamline workflows and maintain scientific and regulatory rigor from discovery through development.”

Key highlights of this release include:

  • Enhancements to the Integral public REST API, including new endpoints and behavioral improvements to strengthen automation and interoperability.
  • Features delivering functional, usability, and performance improvements in targeted areas of the product to optimize daily workflows.

In addition to these updates, Integral continues to offer capabilities that make it a natural complement to Phoenix PK/PD software and a trusted cornerstone of PK data management, these include:

  • File versioning and savepoints to track analysis history and ensure reproducibility
  • Configurable folder structures with full access control for secure collaboration
  • Smart management of file dependencies and updates to maintain workflow consistency
  • Alerts and notifications to keep users informed of changes and reviews

Learn more about the Integral Data Repository at: https://www.certara.com/integral-data-repository/

Certara(サターラ)について

サターラは、バイオシミュレーションソフトウェア、技術、サービスを用いて医薬品を加速し、従来の創薬・医薬品開発を変革します。製薬、教育機関、規制当局のお客様 2,600人以上、70ヵ国にてサターラの技術やサービスが活用されています。Visit us at www.certara.com. 

サターラの問い合わせ先:

Sheila Rocchio
[email protected]

報道機関の皆様:

赤津笑美 (emi.akatsu@certara.com)
[email protected]

Integral データリポジトリの詳細はお気軽にご相談ください

Integral は、GxP/非GxP試験の両方におけるデータライフサイクルをPKサイエンティストが管理するための包括的な機能を提供し、解析業務を支援するとともに、業務効率の向上を実現します。

詳細を表示
Powered by Translations.com GlobalLink Web Software